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The AMP-activated protein kinase (AMPK) is a cellular
energy sensor that is conserved throughout the eukaryotic
domain. AMPK exists as complexes comprising catalytic a
subunits and regulatory b and g subunits, which are acti-
vated >100-fold by phosphorylation of the a subunit at
Thr-172 by upstream kinases. Binding of AMP to one site
on the Y subunit causes 10-fold allosteric activation by
AMP, while binding of either AMP or ADP to a second
site promotes phosphorylation and inhibits dephosphory-
lation of Thr-172. Since both effects are antagonized by
ATP, the kinase is activated by falling cellular energy sta-
tus, when it phosphorylates downstream targets that
switch on catabolic pathways generating ATP, while
switching off processes consuming ATP. Catabolic pro-
cesses switched on including uptake and metabolism of
glucose and fatty acids, and mitochondrial biogenesis.
ATP-consuming processes switched off include biosyn-
thetic pathways for lipids (fatty acids, phospholipids, cho-
lesterol), carbohydrates (gluconeogenesis, glycogen
synthesis), proteins and ribosomal RNA, and progress
through the cell cycle.
By switching on glucose and fatty acid uptake and meta-
bolism and switching off gluconeogenesis, AMPK should
reverse the key metabolic defects in insulin resistance and
type 2 diabetes. Consistent with this, AMPK is a target,
although probably not the only target, for the anti-diabetic
drug metformin. Because AMPK activation inhibits most
biosynthetic pathways and causes cell cycle arrest, it
should also have a cytostatic, tumor suppressor effect. The
discovery in 2003 that the major upstream kinase that
phosphorylates Thr-172 is the tumor suppressor kinase,
LKB1, strengthened this view. The finding also led to ret-
rospective analyses suggesting that metformin protects
against the development of cancer.
If AMPK is a tumor suppressor, one would expect that it
would be down-regulated in many tumors. This indeed
occurs through loss-of-function mutations in the upstream
kinase LKB1, particularly in non-small cell lung cancer
and cervical cancer. The majority of cases of breast cancer
also appear to have defects in AMPK activation, although
the mechanism is not known. We have found that AMPK
is down-regulated in cells infected with hepatitis C virus
(HCV). HCV may switch off AMPK to prevent its inhibi-
tory effects on lipid and protein synthesis, required for
viral replication. HCV infection activates the PKB/Akt
pathway, leading to phosphorylation of the a1 subunit of
AMPK on Ser-485, thus inhibiting AMPK activation via
phosphorylation at Thr-172. It is possible that this contri-
butes to the elevated risk of hepatocellular carcinoma
observed in humans with chronic HCV infection.
Finally, we have found that AMPK is directly activated
by salicylate, and have evidence that at least some of the
metabolic changes induced by the drug in vivo are
mediated by AMPK. Salicylate is a natural product of
plants whose medicinal use was described in ancient
manuscripts. Its use has largely been replaced by deriva-
tives such as salsalate and aspirin, but both are rapidly
broken down to salicylate in vivo. It is possible that some
of the beneficial effects of salicylate derivatives, including
amelioration of insulin resistance and protection against
colon cancer, might be mediated by AMPK.
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